Cargando…
TLR9 signaling through NF-κB/RELA and STAT3 promotes tumor-propagating potential of prostate cancer cells
Prostate cancer progression was associated with tumorigenic signaling activated by proinflammatory mediators. However, the etiology of these events remains elusive. Here, we demonstrate that triggering of the innate immune receptor, Toll-like Receptor 9 (TLR9), in androgen-independent prostate cance...
Autores principales: | Moreira, Dayson, Zhang, Qifang, Hossain, Dewan Md S., Nechaev, Sergey, Li, Haiqing, Kowolik, Claudia M., D'Apuzzo, Massimo, Forman, Stephen, Jones, Jeremy, Pal, Sumanta K., Kortylewski, Marcin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4627309/ https://www.ncbi.nlm.nih.gov/pubmed/26046794 |
Ejemplares similares
-
Targeted TLR9-activation/STAT3-blocking abrogates immunosuppressive functions of myeloid-derived suppressor cells from late-stage prostate cancer patients
por: Md Sakib Hossain, Dewan, et al.
Publicado: (2014) -
Systemic delivery of TLR9-activating/STAT3-blocking oligonucleotides induces leukemia regression
por: Zhang, Qifang, et al.
Publicado: (2014) -
Cell-selective oligonucleotide STAT3 inhibitor for immunotherapy of human acute myeloid leukemia
por: Zhang, Qifang, et al.
Publicado: (2015) -
B Cell Lymphoma Immunotherapy Using TLR9-Targeted Oligonucleotide STAT3 Inhibitors
por: Zhao, Xingli, et al.
Publicado: (2018) -
The dark side of Toll-like receptor signaling: TLR9 activation limits the efficacy cancer radiotherapy
por: Kortylewski, Marcin, et al.
Publicado: (2014)